Mukka Proteins Approves Issue of 2 Crore Warrants and Strategic Capital Contributions in Fish Industry Firms

Mukka Proteins Approves Issue of 2 Crore Warrants and Strategic Capital Contributions in Fish Industry Firms

Mukka Proteins Approves Issue of 2 Crore Warrants and Strategic Capital Contributions in Fish Industry Firms​

Mukka Proteins Limited has approved significant corporate actions following a Board meeting held on June 12, 2026. The company sanctioned the issue of up to 2 crore Fully Convertible Warrants (Warrants) to non-promoter entities, totaling an aggregate value of Rs 47,00,00,000/- at an issue price of Rs 23.50 per Warrant. Furthermore, the Board approved strategic investments through capital contributions in two partnership firms focused on fish meal and fish oil production.

The preferential allotment of warrants is designed for identified non-promoter persons and entities and allows each warrant to be convertible into one fully paid-up equity share of face value Rs 1/-. The company stated that the allotment process was conducted in accordance with SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018.

The Warrants are scheduled to be allotted to various non-promoter entities up to a maximum of 2 crore. Key allottees and their proposed allocation numbers include:

Name of Proposed AllotteeCategoryMaximum Warrants Proposed
Mr. Vishal ManiarNon-Promoter25,00,000
Mr. Irfan ChapraNon-Promoter21,75,000
Ms. Reshma ChapraNon-Promoter21,75,000
Mr. Hiren Hiralal ShiyalNon-Promoter22,50,000

Other recipients of warrants included Ms. Payal Maniar (12,00,000), Mr. Jasbir Singh Batra (5,00,000), and several other non-promoters, totaling the proposed issuance up to 2 crore Warrants for an aggregate amount of Rs 47,00,00,000/-.

Strategic Investments in Fisheries Sector​

The Board also approved two capital investments aimed at expanding the company's core business operations within the fish industry:

1. Delta Marine Products: The company approved a capital contribution not exceeding Rs 11,10,00,000/- to Delta Marine Products, a manufacturing entity specializing in fish meal and fish oil. This investment is intended as part of the strategic plan to expand core business capacity, improve production efficiency, and broaden market reach.
2. Aqua Marine: Approval was granted for a capital contribution not exceeding Rs 15,00,00,000/- to Aqua Marine, which is also involved in the manufacturing of fish meals and fish oil.

The details regarding these strategic investments are presented below:

Target EntityInvestment Limit (Capital Contribution)Acquired StakeBusiness Focus
Delta Marine ProductsUp to Rs 11,10,00,000/-51%Manufacturing fish meal and fish oil.
Aqua MarineUp to Rs 15,00,00,000/-51%Manufacturing fish meals and fish oil.

Key Terms and E-Voting Schedule​

The company confirmed that the Warrants can be converted into fully paid-up equity shares of face value Rs 1/- within a period of 18 months from the date of allotment, subject to required statutory and regulatory approvals. Upon conversion, the Equity Shares will rank pari passu with existing shares of the Company.

The Board also took note that the 'Relevant Date' for determining the minimum issue price is June 12, 2026. The company approved a draft Postal Ballot Notice and set the following timeline for seeking members' approval on these matters:

ParticularsDetails
Cut-off date for E-votingJune 10, 2026
E-voting periodSaturday, June 13, 2026 (9:00 A.M. IST) to Sunday, July 12, 2026 (5:00 P.M. IST)

Additionally, the Board appointed Mr Chethan Nayak K and Mrs Ujala Rani as Scrutinizers for conducting the Postal Ballot voting process through electronic means.

MUKKA Stock Price Movement​

Today, Mukka Proteins Limited shares surged in a strong close, settling at ₹22.81 after the equity gained 8.74%. The security saw robust institutional demand, with over 1.02 million shares traded during the session.
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Last edited by a moderator:

Editorial Note

This news article was written and created by Himanshu, and published on IST.
Back
Top